查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2035955

2026年全球單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場報告

Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，用於檢測單純皰疹病毒 (HSV) 的聚合酵素鏈鎖反應(PCR) 檢測市場規模顯著擴大。預計該市場將從 2025 年的 11.8 億美元成長至 2026 年的 12.8 億美元，複合年成長率 (CAGR) 為 8.0%。過去幾年的成長歸因於以下因素：HSV 感染在全球範圍內的流行率上升、人們對性行為感染感染的認知提高、分子診斷檢查室的擴張、核酸增幅檢查以及抗病毒療法的可及性改善。

。

預計未來幾年單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場將保持強勁成長。預計到 2030 年，該市場將以 8.2% 的複合年成長率成長，達到 17.5 億美元。預測期內的成長主要歸功於以下因素：常規 HSV篩檢計畫的日益普及、對快速照護現場分子檢測需求的成長、感染疾病精準醫療方法的推廣、新興市場醫療保健投資的增加，以及多重 PCR 和定量 PCR 平台技術的進步。預測期內的關鍵趨勢包括：即時PCR在 HSV 快速檢測中的應用日益廣泛、新生兒和生殖器 HSV 病例早期診斷需求的成長、多重 PCR 檢測在鑑別診斷中的應用日益廣泛、高靈敏度定量 PCR 檢測的普及，以及自動化「檢體到結果」平台的整合。

預計未來幾年，感染疾病的上升將推動單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場的擴張。當有害微生物進入人體並在體內繁殖時，就會發生感染疾病，並可能導致疾病。都市化是導致感染疾病上升的一個因素，因為都市區人口密度高，透過密切接觸和資源共用會加速病原體的傳播。單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測能夠快速且準確地檢測 HSV DNA，從而實現早期診斷和治療，有助於防止感染惡化和傳播。例如，英國英國安全局報告稱，2023 年英格蘭地區酵母菌相關血流感染疾病的發生率比 2022 年增加了 4%。因此，感染疾病的上升正在推動單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場的成長。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 人工智慧和自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
  • 主要趨勢
    • 即時PCR技術在HSV快速檢測的應用日益廣泛。
    • 對新生兒和生殖器皰疹病例早期診斷的需求日益成長
    • 多重PCR檢測在鑑別診斷的應用日益廣泛
    • 高靈敏度定量PCR檢測的廣泛應用
    • 自動化樣本到結果平台的整合正在推進。

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 研究機構
  • 公共衛生研究所
  • 血庫

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場：規模、比較和成長率分析
  • 全球單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場表現：規模和成長，2020-2025 年
  • 全球單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場預測：規模和成長，2025-2030 年，2035 年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按測試類型
  • 聚合酵素鏈鎖反應檢測、血清學檢測、培養檢測
  • 依產品類型
  • 儀器、試劑及試劑盒、軟體
  • 依樣本類型
  • 水痘拭子或體液樣本、腦脊髓液樣本、血液或血清樣本
  • 透過使用
  • 臨床診斷、檢查、血液篩檢及其他應用
  • 最終用戶
  • 醫院、診所、診斷檢測實驗室、研究機構和其他最終用戶
  • 細分（按類型）：聚合酵素鏈鎖反應(PCR) 檢測
  • 即時聚合酵素鏈鎖反應、嵌套聚合酵素鏈鎖反應、多重聚合酵素鏈鎖反應、定量聚合酵素鏈鎖反應
  • 細分（按類型）：血清學檢測
  • IgM抗體檢測、IgG抗體檢測、 西方墨點法法、酵素免疫分析法
  • 細分（按類型）：培養測試
  • 細胞培養分離、斑塊試驗培養、殼管瓶培養、組織培養感染試驗

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場：競爭格局與市場佔有率，2024年
  • 單純皰疹病毒 (HSV)聚合酵素鏈鎖反應(PCR) 檢測市場：公司估值矩陣
  • 單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Becton

第37章 其他大型企業和創新企業

  • Dickinson Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN NV, DiaSorin SpA, Promega Corporation, Meridian Bioscience Inc., Seegene Inc., BioPerfectus Technologies Co. Ltd., altona Diagnostics GmbH, Xi'an Tianlong Science & Technology Co. Ltd., 3B BlackBio Dx Limited, GeneProof sro

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場：提供新機會的國家
  • 2030年單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場：提供新機會的細分市場
  • 2030年單純皰疹病毒（HSV）聚合酵素鏈鎖反應（PCR）檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: ME4MHSVH01_G26Q2

Herpes simplex virus (HSV) polymerase chain reaction (PCR) testing is a molecular diagnostic technique that detects HSV DNA in clinical specimens such as blood, swabs, or cerebrospinal fluid. It provides rapid, highly sensitive, and specific identification of HSV infections, including genital, oral, or neonatal cases. This testing supports early diagnosis, guides antiviral therapy, and helps prevent transmission of the infection.

The key test types of herpes simplex virus (HSV) polymerase chain reaction (PCR) testing include polymerase chain reaction testing, serology testing, and culture testing. PCR testing amplifies and detects specific DNA or RNA sequences to identify pathogens or genetic material with high sensitivity and accuracy. Product types include instruments, reagents and kits, and software, used with sample types such as vesicular swabs or fluid samples, cerebrospinal fluid samples, and blood or serum samples. Applications include clinical diagnostics, research, blood screening, and others, serving hospitals and clinics, diagnostic laboratories, research institutes, and other end users.

Tariffs on imported PCR instruments, reagents, and molecular diagnostic components are influencing the HSV PCR testing market by increasing procurement and operational costs for hospitals and diagnostic laboratories. Segments such as instruments and reagents and kits are most affected, particularly in regions reliant on imported diagnostic systems, including parts of Asia-Pacific, Latin America, and Africa. Higher costs may limit accessibility in low-resource settings; however, tariffs are also encouraging domestic production of PCR kits and localized manufacturing of diagnostic equipment, supporting supply chain resilience and regional innovation over the long term.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market research report is one of a series of new reports from The Business Research Company that provides herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market statistics, including herpes simplex virus (HSV) polymerase chain reaction (PCR) testing industry global market size, regional shares, competitors with a herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market share, detailed herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market segments, market trends and opportunities, and any further data you may need to thrive in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing industry. This herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market size has grown strongly in recent years. It will grow from $1.18 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising global prevalence of hsv infections, increasing awareness of sexually transmitted infections, expansion of molecular diagnostic laboratories, growing adoption of nucleic acid amplification tests, increasing availability of antiviral therapies

.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market size is expected to see strong growth in the next few years. It will grow to $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing implementation of routine hsv screening programs, rising demand for rapid point-of-care molecular testing, expansion of precision medicine approaches in infectious diseases, increasing healthcare investments in emerging markets, technological advancements in multiplex and quantitative pcr platforms. Major trends in the forecast period include increasing adoption of real-time pcr for rapid hsv detection, rising demand for early diagnosis in neonatal and genital hsv cases, growing use of multiplex pcr assays for differential diagnosis, expansion of high-sensitivity quantitative pcr testing, increasing integration of automated sample-to-result platforms.

The rising occurrence of infections is anticipated to drive the expansion of the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market in the coming years. Infections occur when harmful microorganisms invade and grow within the body, potentially causing illness. Urbanization contributes to the increase in infections, as higher population densities in cities promote faster transmission of pathogens through close human contact and shared resources. Herpes simplex virus (HSV) polymerase chain reaction (PCR) testing aids by rapidly and accurately detecting HSV DNA, facilitating early diagnosis and treatment, which prevents the infection from worsening or spreading to others. For example, in 2023, the UK Health Security Agency, a government body in the UK, reported that the rate of yeast-related bloodstream infections across England increased by 4% compared to 2022. Hence, the rising occurrence of infections is fueling the growth of the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market.

Leading companies operating in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market are focusing on developing innovative solutions such as point-of-care molecular diagnostics to enable rapid, accurate, and decentralized detection of HSV infections for improved patient management. Point-of-care molecular diagnostics refers to tests that detect pathogens rapidly and accurately at the site of patient care without the need for a central laboratory. For example, in January 2023, Molbio Diagnostics Pvt. Ltd., an India-based medical technology company, launched a Truenat HSV 1/2 chip-based RT-PCR test for diagnosing herpes simplex virus types 1 and 2. This portable, point-of-care assay delivers results in under one hour from genital swabs or cerebrospinal fluid (CSF) using the battery-operated Truelab platform, requires no additional equipment, and holds central drugs standard control organisation (CDSCO) approval in India. It supports rapid detection of active herpes simplex virus (HSV) infections to boost awareness and early treatment amid rising cases.

In May 2024, Bruker Corporation, a US-based scientific instruments and diagnostics company, acquired ELITech Group for an undisclosed sum. With this acquisition, Bruker seeks to broaden its footprint in polymerase chain reaction (PCR) molecular diagnostics and enhance its clinical laboratory diagnostic offerings by utilizing ELITech Group's molecular diagnostic systems, infectious disease assays, and microbiology solutions, thereby strengthening Bruker's market presence and service capabilities for clinical laboratories. ELITech Group is a France-based molecular diagnostic company providing herpes simplex virus (HSV) PCR testing solutions.

Major companies operating in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Promega Corporation, Meridian Bioscience Inc., Seegene Inc., BioPerfectus Technologies Co. Ltd., altona Diagnostics GmbH, Xi'an Tianlong Science & Technology Co. Ltd., 3B BlackBio Dx Limited, GeneProof s.r.o., Primerdesign Ltd., BioHelix Corporation.

North America was the largest region in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market consists of revenues earned by entities by providing services such as quantitative viral load analysis, confirmation of suspected cases, prenatal and neonatal screening, and monitoring of treatment efficacy. The market value includes the value of related goods sold by the service provider or included within the service offering. The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market also includes sales of control and calibration materials, viral transport media, swabs and sample collection devices, automated nucleic acid extraction systems, microfluidic cartridges, and laboratory automation accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses herpes simplex virus (hsv) polymerase chain reaction (pcr) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for herpes simplex virus (hsv) polymerase chain reaction (pcr) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The herpes simplex virus (hsv) polymerase chain reaction (pcr) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Polymerase Chain Reaction Testing; Serology Testing; Culture Testing
  • 2) By Product Type: Instruments; Reagents And Kits; Software
  • 3) By Sample Type: Vesicular Swabs or Fluid Samples; Cerebrospinal Fluid Samples; Blood or Serum Samples
  • 4) By Application: Clinical Diagnostics; Research; Blood Screening; Other Applications
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Polymerase Chain Reaction Testing: Real Time Polymerase Chain Reaction; Nested Polymerase Chain Reaction; Multiplex Polymerase Chain Reaction; Quantitative Polymerase Chain Reaction
  • 2) By Serology Testing: IgM Antibody Testing; IgG Antibody Testing; Western Blot Testing; Enzyme Linked Immunosorbent Assay
  • 3) By Culture Testing: Cell Culture Isolation; Plaque Assay Culture; Shell Vial Culture; Tissue Culture Infection Assay
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton; Dickinson Company; Quest Diagnostics Incorporated; Hologic Inc.; bioMerieux SA; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A.; Promega Corporation; Meridian Bioscience Inc.; Seegene Inc.; BioPerfectus Technologies Co. Ltd.; altona Diagnostics GmbH; Xi'an Tianlong Science & Technology Co. Ltd.; 3B BlackBio Dx Limited; GeneProof s.r.o.; Primerdesign Ltd.; BioHelix Corporation.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Real-Time PCR for Rapid HSV Detection
    • 4.2.2 Rising Demand for Early Diagnosis in Neonatal and Genital HSV Cases
    • 4.2.3 Growing Use of Multiplex PCR Assays for Differential Diagnosis
    • 4.2.4 Expansion of High-Sensitivity Quantitative PCR Testing
    • 4.2.5 Increasing Integration of Automated Sample-to-Result Platforms

5. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Public Health Laboratories
  • 5.5 Blood Banks

6. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Segmentation

  • 9.1. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction Testing, Serology Testing, Culture Testing
  • 9.2. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents And Kits, Software
  • 9.3. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Vesicular Swabs or Fluid Samples, Cerebrospinal Fluid Samples, Blood or Serum Samples
  • 9.4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Diagnostics, Research, Blood Screening, Other Applications
  • 9.5. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
  • 9.6. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Polymerase Chain Reaction Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Real Time Polymerase Chain Reaction, Nested Polymerase Chain Reaction, Multiplex Polymerase Chain Reaction, Quantitative Polymerase Chain Reaction
  • 9.7. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Serology Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • IgM Antibody Testing, IgG Antibody Testing, Western Blot Testing, Enzyme Linked Immunosorbent Assay
  • 9.8. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Culture Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell Culture Isolation, Plaque Assay Culture, Shell Vial Culture, Tissue Culture Infection Assay

10. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Regional And Country Analysis

  • 10.1. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 11.1. Asia-Pacific Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 12.1. China Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 13.1. India Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 14.1. Japan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 15.1. Australia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 16.1. Indonesia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 17.1. South Korea Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 18.1. Taiwan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 19.1. South East Asia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 20.1. Western Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 21.1. UK Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 22.1. Germany Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 23.1. France Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 24.1. Italy Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 25.1. Spain Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 26.1. Eastern Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 27.1. Russia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 28.1. North America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 29.1. USA Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 30.1. Canada Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 31.1. South America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 32.1. Brazil Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 33.1. Middle East Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 34.1. Africa Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Regulatory and Investment Landscape

36. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Company Profiles

  • 36.1. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Overview, Products and Services, Strategy and Financial Analysis

37. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Other Major And Innovative Companies

  • Dickinson Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Promega Corporation, Meridian Bioscience Inc., Seegene Inc., BioPerfectus Technologies Co. Ltd., altona Diagnostics GmbH, Xi'an Tianlong Science & Technology Co. Ltd., 3B BlackBio Dx Limited, GeneProof s.r.o.

38. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

41. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market High Potential Countries, Segments and Strategies

  • 41.1 Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer